Ngā hua rapu - Nima Rezaei

Whakamahine hua
  1. 1
    COVID-19 affects healthy pediatricians more than pediatric patients

    COVID-19 affects healthy pediatricians more than pediatric patients mā Nima Rezaei

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Immune-epidemiological parameters of the novel coronavirus – a perspective

    Immune-epidemiological parameters of the novel coronavirus – a perspective mā Amene Saghazadeh, Nima Rezaei

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Case Report: Death due to COVID-19 in Three Brothers

    Case Report: Death due to COVID-19 in Three Brothers mā Sedigheh Yousefzadegan, Nima Rezaei

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Genetic predisposition models to COVID-19 infection

    Genetic predisposition models to COVID-19 infection mā Farzaneh Darbeheshti, Nima Rezaei

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids

    Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids mā Amene Saghazadeh, Nima Rezaei

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Central Nervous System Involvement in COVID-19

    Central Nervous System Involvement in COVID-19 mā Leila Jahanshahlu, Nima Rezaei

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    SARS‐CoV‐2: A comprehensive review from pathogenicity of the virus to clinical consequences

    SARS‐CoV‐2: A comprehensive review from pathogenicity of the virus to clinical consequences mā Melika Lotfi, Nima Rezaei

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Lymphopenia in COVID‐19: Therapeutic opportunities

    Lymphopenia in COVID‐19: Therapeutic opportunities mā Nazanin Fathi, Nima Rezaei

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Monoclonal antibody as a potential anti-COVID-19

    Monoclonal antibody as a potential anti-COVID-19 mā Leila Jahanshahlu, Nima Rezaei

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Primary Immunodeficiency Diseases in COVID-19 Pandemic: A Predisposing or Protective Factor?

    Primary Immunodeficiency Diseases in COVID-19 Pandemic: A Predisposing or Protective Factor? mā Fateme Babaha, Nima Rezaei

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment

    COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment mā Shaghayegh Sadeghmousavi, Nima Rezaei

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    CRISPR/Cas13: A potential therapeutic option of COVID-19

    CRISPR/Cas13: A potential therapeutic option of COVID-19 mā Melika Lotfi, Nima Rezaei

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Role of Toll‐like receptors in the pathogenesis of COVID‐19

    Role of Toll‐like receptors in the pathogenesis of COVID‐19 mā Shaghayegh Khanmohammadi, Nima Rezaei

    I whakaputaina 2021
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Long Non-Coding RNAs in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-of-the-Art Review

    Long Non-Coding RNAs in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-of-the-Art Review mā Sara Momtazmanesh, Nima Rezaei

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Autoimmune complications of COVID‐19

    Autoimmune complications of COVID‐19 mā Niloufar Yazdanpanah, Nima Rezaei

    I whakaputaina 2021
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Poxviruses and the immune system: Implications for monkeypox virus

    Poxviruses and the immune system: Implications for monkeypox virus mā Amene Saghazadeh, Nima Rezaei

    I whakaputaina 2022
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Insights on Mpox virus infection immunopathogenesis

    Insights on Mpox virus infection immunopathogenesis mā Amene Saghazadeh, Nima Rezaei

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Eosinophils in the tumor microenvironment: implications for cancer immunotherapy

    Eosinophils in the tumor microenvironment: implications for cancer immunotherapy mā Sasan Ghaffari, Nima Rezaei

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Dysregulation of the immune response in coronavirus disease 2019

    Dysregulation of the immune response in coronavirus disease 2019 mā Leila Mohamed Khosroshahi, Nima Rezaei

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Immune checkpoint inhibition in COVID-19: risks and benefits

    Immune checkpoint inhibition in COVID-19: risks and benefits mā Parmida Sadat Pezeshki, Nima Rezaei

    I whakaputaina 2021
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: